{"id":364740,"date":"2025-10-25T11:00:28","date_gmt":"2025-10-25T05:30:28","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=364740"},"modified":"2025-10-25T09:31:04","modified_gmt":"2025-10-25T04:01:04","slug":"sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/","title":{"rendered":"SAM &amp; Co. advises Jusmiral Holdings Ltd. on ~USD 350 Million &#8216;On-Market Sale&#8217; of Shares in Cohance Lifesciences Ltd."},"content":{"rendered":"<div style=\"text-align: justify; line-height: 150%;\">\n<p style=\"margin-bottom: 3%;\">Shardul Amarchand Mangaldas &amp; Co. (SAM) acted as the legal advisor for an on-market sale of 8.93% shareholding in Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) for approximately USD 350 million (INR 3,093 Crores), by Jusmiral Holdings Limited, which is controlled by funds managed by Advent International.<\/p>\n<p style=\"margin-bottom: 3%;\">SAM has earlier advised Advent in its control acquisition of Suven Pharmaceuticals Limited by way of a share purchase and mandatory open offer. SAM also advised on the subsequent merger of Cohance with and into Suven, upon which Suven was renamed as Cohance.<\/p>\n<p style=\"margin-bottom: 3%;\">The SAM transaction team was led by Ambarish, Partner; Krishaal Morjaria, Principal Associate; and Varun Natarajan, Senior Associate. The securities law team was led by Kanwardeep Singh Kapany, Counsel. Ameya Gokhale, Partner and Kriti Kalyani, Principal Associate, also provided inputs.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p style=\"font-style: italic;\">SAM has earlier advised Advent in its control acquisition of Suven Pharmaceuticals Limited by way of a share purchase and mandatory open offer.<\/p>\n","protected":false},"author":67011,"featured_media":364741,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[40943,91418,31359,91417,81020,91419,58260,91420],"class_list":["post-364740","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-capital-markets","tag-cohance-lifesciences","tag-corporate-law","tag-jusmiral-holdings","tag-ma-advisory","tag-on-market-sale","tag-sam-co","tag-usd-350-million-deal"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.4 (Yoast SEO v26.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>SAM &amp; Co. Advises Jusmiral Holdings on USD 350 Million On-Market Sale of Shares in Cohance Lifesciences | SCC Times<\/title>\n<meta name=\"description\" content=\"SAM &amp; Co. acted as legal advisor to Jusmiral Holdings Ltd. in its ~USD 350 million on-market sale of shares in Cohance Lifesciences Ltd., marking a significant capital markets transaction.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SAM &amp; Co. advises Jusmiral Holdings Ltd. on ~USD 350 Million &#039;On-Market Sale\u2019 of Shares in Cohance Lifesciences Ltd.\" \/>\n<meta property=\"og:description\" content=\"SAM &amp; Co. acted as legal advisor to Jusmiral Holdings Ltd. in its ~USD 350 million on-market sale of shares in Cohance Lifesciences Ltd., marking a significant capital markets transaction.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-25T05:30:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/SAM-amp-Co.-advises-Jusmiral-Holdings.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"SAM &amp; Co. advises Jusmiral Holdings Ltd. on ~USD 350 Million &#039;On-Market Sale&#8217; of Shares in Cohance Lifesciences Ltd.\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/\",\"name\":\"SAM & Co. Advises Jusmiral Holdings on USD 350 Million On-Market Sale of Shares in Cohance Lifesciences | SCC Times\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/SAM-amp-Co.-advises-Jusmiral-Holdings.webp\",\"datePublished\":\"2025-10-25T05:30:28+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"SAM & Co. acted as legal advisor to Jusmiral Holdings Ltd. in its ~USD 350 million on-market sale of shares in Cohance Lifesciences Ltd., marking a significant capital markets transaction.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/#primaryimage\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/SAM-amp-Co.-advises-Jusmiral-Holdings.webp\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/SAM-amp-Co.-advises-Jusmiral-Holdings.webp\",\"width\":886,\"height\":590,\"caption\":\"SAM &amp; Co. advises Jusmiral Holdings\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SAM &amp; Co. advises Jusmiral Holdings Ltd. on ~USD 350 Million &#8216;On-Market Sale&#8217; of Shares in Cohance Lifesciences Ltd.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"SAM & Co. Advises Jusmiral Holdings on USD 350 Million On-Market Sale of Shares in Cohance Lifesciences | SCC Times","description":"SAM & Co. acted as legal advisor to Jusmiral Holdings Ltd. in its ~USD 350 million on-market sale of shares in Cohance Lifesciences Ltd., marking a significant capital markets transaction.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/","og_locale":"en_US","og_type":"article","og_title":"SAM & Co. advises Jusmiral Holdings Ltd. on ~USD 350 Million 'On-Market Sale\u2019 of Shares in Cohance Lifesciences Ltd.","og_description":"SAM & Co. acted as legal advisor to Jusmiral Holdings Ltd. in its ~USD 350 million on-market sale of shares in Cohance Lifesciences Ltd., marking a significant capital markets transaction.","og_url":"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2025-10-25T05:30:28+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/SAM-amp-Co.-advises-Jusmiral-Holdings.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_title":"SAM &amp; Co. advises Jusmiral Holdings Ltd. on ~USD 350 Million 'On-Market Sale&#8217; of Shares in Cohance Lifesciences Ltd.","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/","url":"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/","name":"SAM & Co. Advises Jusmiral Holdings on USD 350 Million On-Market Sale of Shares in Cohance Lifesciences | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/SAM-amp-Co.-advises-Jusmiral-Holdings.webp","datePublished":"2025-10-25T05:30:28+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"SAM & Co. acted as legal advisor to Jusmiral Holdings Ltd. in its ~USD 350 million on-market sale of shares in Cohance Lifesciences Ltd., marking a significant capital markets transaction.","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/SAM-amp-Co.-advises-Jusmiral-Holdings.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/SAM-amp-Co.-advises-Jusmiral-Holdings.webp","width":886,"height":590,"caption":"SAM &amp; Co. advises Jusmiral Holdings"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"SAM &amp; Co. advises Jusmiral Holdings Ltd. on ~USD 350 Million &#8216;On-Market Sale&#8217; of Shares in Cohance Lifesciences Ltd."}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/SAM-amp-Co.-advises-Jusmiral-Holdings.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":347815,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/","url_meta":{"origin":364740,"position":0},"title":"JSA Advises Advent International and Suven Pharmaceuticals on USD 3 Billion Merger with Cohance Lifesciences","author":"Editor","date":"May 14, 2025","format":false,"excerpt":"JSA advised Advent International and Suven Pharmaceuticals Limited, which is listed in India, in the ~USD 3 billion dollar (combined) merger of Cohance Lifesciences Limited with and into Suven Pharmaceuticals Limited, as one of the largest transactions of its kind. Following the merger, Suven Pharmaceuticals Limited has now been renamed\u2026","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"JSA Advises Advent International","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-Advises-Advent-International.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-Advises-Advent-International.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-Advises-Advent-International.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-Advises-Advent-International.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":283450,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/","url_meta":{"origin":364740,"position":1},"title":"Khaitan &amp; Co. advises Eris Group on its acquisition of a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited","author":"Bhumika Indulia","date":"February 8, 2023","format":false,"excerpt":"DEAL DETAILS Eris Lifesciences Limited | Brand agreement and supply of agreement between Eris Lifesciences Limited and Glenmark Pharmaceuticals Limited NO HEADINGS DETAILS 1. Sector Pharmaceutical Industry 2. Announcement Date 17-Jan-2023 3. Completion Date 17-Jan-2023 4. Name of Client Eris Lifesciences Limited Eris Lifesciences Ltd is a publicly listed Indian\u2026","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/02\/MicrosoftTeams-image-339.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":368864,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/","url_meta":{"origin":364740,"position":2},"title":"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited","author":"Editor","date":"December 5, 2025","format":false,"excerpt":"SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals, making it a wholly owned subsidiary.","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Eris Lifesciences Swiss Parenterals acquisition","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":308625,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/12\/07\/sam-advises-eris-lifesciences-limited-acquisition-of-dermatology-and-nephrology-branded-formulations-business-units\/","url_meta":{"origin":364740,"position":3},"title":"SAM advises Eris Lifesciences Limited on its acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics Limited in India","author":"Bhumika Indulia","date":"December 7, 2023","format":false,"excerpt":"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on its acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics Limited (\u201cBiocon\u201d) in India. The deal is valued at approximately INR 366 crores and the date of closing the deal was 10 November 2023. This acquisition marks the\u2026","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Eris Lifesciences Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":315201,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/","url_meta":{"origin":364740,"position":4},"title":"Shardul Amarchand Mangaldas &amp; Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited","author":"Bhumika Indulia","date":"February 24, 2024","format":false,"excerpt":"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on the acquisition of a majority stake in Swiss Parenterals Limited (\u201cSPL\u201d) from the existing shareholders of SPL by Eris and certain individual purchasers. The aggregate deal value is approximately INR 875 Crores (USD 105.38 million). The consideration was paid through a\u2026","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Eris Lifesciences Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":369560,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/","url_meta":{"origin":364740,"position":5},"title":"Shardul Amarchand Mangaldas &#038; Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion","author":"Editor","date":"December 11, 2025","format":false,"excerpt":"Shardul Amarchand Mangaldas advised Biocon Limited on its ~USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics from multiple investors.","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Biocon Biologics integration","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp?resize=700%2C400&ssl=1 2x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/364740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=364740"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/364740\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/364741"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=364740"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=364740"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=364740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}